Immunization with Epstein–Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge
Epstein–Barr virus (EBV) is the primary cause of infectious mononucleosis and is strongly implicated in the etiology of multiple lymphoid and epithelial cancers. EBV core fusion machinery envelope proteins gH/gL and gB coordinately mediate EBV fusion and entry into its target cells, B lymphocytes an...
Main Authors: | Xinle Cui, Zhouhong Cao, Yuriko Ishikawa, Sara Cui, Ken-Ichi Imadome, Clifford M. Snapper |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/3/285 |
Similar Items
-
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
by: Xinle Cui, et al.
Published: (2021-10-01) -
Chronic Active Epstein–Barr Virus Infection
by: Li Jun, et al.
Published: (2012-06-01) -
Epstein-Barr Virus Myocarditis Presenting as Acute Abdomen in a Child: a Case Report
by: Roshni Chakraborty, et al.
Published: (2015-10-01) -
Genotypes of Epstein–Barr virus (EBV1/EBV2) in individuals with infectious mononucleosis in the metropolitan area of Belém, Brazil, between 2005 and 2016
by: Talita Antonia Furtado Monteiro, et al.
Published: (2020-07-01) -
Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
by: James P. Dugan, et al.
Published: (2019-03-01)